New Drug Pricing and Market Access [Podcast]

What goes into pricing a new drug? In this month’s episode of The Life Science Report Dr. Peter Bak, Brendan Wang and Christian Thienel discuss pricing and market access, especially as it relates to Biogen’s now FDA-approved Aduhelm (aducanumab).

Listen to our conversation on pricing in our latest industry insider podcast. And as always, reach out with questions or comments.